We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Robot-Assisted Surgery Helps Cancer Patients Lead Normal Lives

By HospiMedica International staff writers
Posted on 01 Apr 2009
The quality of life of bladder cancer patients treated with robot-assisted cystectomy returned to normal within six months, according to a new study.

Researchers at Roswell Park Cancer Institute (RPCI, Buffalo, NY, USA) conducted a prospective study to examine the quality-of-life (QOL) benefits of robot-assisted cystectomy; QOL was examined using the Functional Assessment of Cancer Therapy questionnaire in 34 patients who underwent robot-assisted surgery between January 2006 and December 2007. More...
The patients were monitored according to U.S. National Comprehensive Cancer Center (NCCN, Fort Washington, PA, USA) guidelines. The average age of the patients was 65 years, and 88% were men. Of all patients, 13% received chemotherapy after surgery. QOL issues were assessed at 1-, 3-, and 6-month intervals.

The researchers found that physical well-being decreased significantly in the first follow-up visit due to the immediate impact of surgery. However, six months later, patients reported their physical activities were comparable with their activities prior to surgery. Emotional scores were statistically higher after surgery, indicating that feelings of sadness and anxiety appeared to be alleviated by the minimally invasive surgery and rapid postrecovery. Scores for social and family support remained uniformly high. The study was published in the March 2009 issue of the British Journal of Urology International (BJUI).

"Patients have indicated that the overall quality of their life after cancer surgery is as important as how long they survive. This study helps us to understand the patient's physical, social, emotional, and functional well-being after surgery," said lead author Khurshid Guru, M.D., director of the department of robotic surgery at RPCI. "Robot-assisted surgery continues to demonstrate its efficacy as a treatment for bladder cancer patients and has now shown its value to patients as they return to life after cancer."

Robot assisted surgery removal of the bladder provides patients with a less invasive treatment option that has several potential advantages over traditional open surgery, including less postoperative pain and fewer days spent in the hospital.

Related Links:

Roswell Park Cancer Institute
U.S. National Comprehensive Cancer Center




Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.